CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1–2 study
2013 ◽
Vol 14
(7)
◽
pp. 590-598
◽
Keyword(s):
Phase 1
◽